Skip to main content

Table 3 Observed and expected number of non-AIDS-defining cancers (NADCs) and all-cause deaths in patients with HIV compared with the general population in Japan

From: Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study

Cancer type

Observed

Expected

SIR (95% CI)

Liver

9

1.9

4.7 (2.1–8.2)

Colorectal

15

7.7

1.9 (1.1–3.0)

Colon

10

4.7

2.1 (1.0–3.7)

Anorectal*

5

3.1

1.6 (0.5–3.4)

Gastric

11

6.0

1.8 (1.0–3.1)

Lung

8

4.4

1.8 (0.8–3.3)

Oral cavity and pharynx

3

1.0

2.9 (0.5–7.0)

Esophageal

2

1.4

1.4 (0.1–4.0)

Pancreas

1

1.2

0.8 (< 0.1–3.3)

Biliary tract

2

0.6

3.2 (0.3–9.2)

Bladder

2

0.8

2.4 (0.2–6.7)

Skin

1

0.6

1.8 (< 0.1–6.9)

Prostate

1

4.0

0.2 (< 0.1–1.0)

Thyroid

1

0.6

1.7 (< 0.1–6.5)

Breast

1

0.8

1.3 (< 0.1–5.0)

Hodgkin lymphoma

4

NAa

NAa

  1. Note. *Anorectal cancer included rectal cancer (n = 2) and anal cancer (n = 3). aGeneral population data were not available for Hodgkin lymphoma
  2. Abbreviation Standardized incidence ratio, SIR standardized mortality ratio